Shree Pacetronix Ltd (SHREEPAC) — shareholding pattern, promoter holding, financials and share price
About Shree Pacetronix Ltd (SHREEPAC)
Shree Pacetronix Ltd operates in the Medical Equipment & Supplies industry, within the Healthcare sector. It trades on the NSE as SHREEPAC and on the BSE under scrip code 527005. Its ISIN is INE847D01010.
Incorporated in 1988, Shree Pacetronix Ltd is in the business of trading of Pacemakers. [1]
Shree Pacetronix Ltd is a manufacturer and exporter of pacemakers, providing critical solutions for heart conditions such as heart failure and arrhythmias.
Established in 1988, the company transitioned into a public limited entity in 1993 and has a production facility in Pithampur, Madhya Pradesh.
Listed peers in Medical Equipment & Supplies: Royal Sense Ltd, KMS Medisurgi Ltd, Amkay Products Ltd, GKB Ophthalmics Ltd, Centenial Surgical Suture Ltd, Galaxy Medicare Ltd.
Valuation & Returns
10 Jul 2026At ₹152.01 a share on 10 Jul 2026, Shree Pacetronix Ltd (SHREEPAC) was valued at a price-to-earnings ratio of 18.15x against an industry P/E of 44.11x and a price-to-book of 4.14x on a book value of ₹36.75 per share as of Mar 2025. Solomo computes return on equity of 22.78% and return on capital employed of 24.51% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 18.15x
- Industry P/E
- 44.11x
- P/B
- 4.14x
- EPS (TTM)
- ₹8.37
- Book value / share
- ₹36.75
- ROE
- 22.78%
- ROCE
- 24.51%
- ROA
- 13.63%
- Debt / equity
- 0.37x
- Dividend yield
- 0%
- EBITDA margin
- 24.78%
- 52-week range
- ₹71 – ₹283.15
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Shree Pacetronix Ltd (SHREEPAC) reported revenue of ₹21.64 crore, net profit of ₹3.14 crore and earnings per share of ₹8.37. That compares with revenue of ₹16.68 crore and net profit of ₹0.75 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹5.37 crore and net profit ₹1.11 crore (consolidated).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 9.23 | 20.26 | 22.04 | 16.68 | 21.64 |
| Net profit (₹ cr) | 0.78 | 3.26 | 3.36 | 0.75 | 3.14 |
| EPS (₹) | 2.17 | 9.06 | 9.33 | 2.08 | 8.37 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 9.55% | 13.91% | 23.02% | -23.77% |
| Profit growth | - | 22.28% | 4.91% | -77.68% |
| Stock price CAGR | 25% | 57% | -10% | 61% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 36.44% of Shree Pacetronix Ltd (SHREEPAC) (up 4.74 pp QoQ). Promoters have pledged 9.4% of their holding. Market capitalisation was ₹57 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2002.
Largest disclosed public shareholders in Jun 2026: BIO-PACE TECHNOLOGY INC 6.56%, Epcot Lifestyles Private Limited 4.25%, ASTRAL TRADEPLACE LLP 3.57%, DHEERAJ KUMAR LOHIA 3.55%, SUNIL KUMAR 2.14%, SONAL LOHIA 1.75%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 36.44% | 9.4% | - | - | 63.56% |
| Mar 2026 | 31.7% | 10.9% | - | - | 68.3% |
| Dec 2025 | 25.8% | 13.6% | 0.14% | - | 74.2% |
| Sep 2025 | 24.25% | 14.8% | 0.14% | - | 75.75% |
| Jun 2025 | 24.25% | 14.8% | - | - | 75.75% |
| Mar 2025 | 24.25% | 14.8% | - | - | 75.75% |
| Dec 2024 | 24.25% | 14.8% | - | - | 75.75% |
| Sep 2024 | 24.25% | 14.8% | - | - | 75.75% |